Citation only
via OpenAlex
P4‐284: Serotonergic blockade prevents age‐related neurodegeneration in C. elegans model of Alzheimer's disease
Jon Pierce‐Shimomura, Ashley Crisp
Alzheimer s & Dementia · 2011
Abstract
Alzheimer's disease (AD) is characterized by the selective degeneration of cholinergic neurons involved in memory. Although the precise etiology of AD remains unclear, the amyloid-precursor protein (APP) is clearly the causal agent in some cases including in Down syndrome where an additional wild-type copy of APP is carried on the 21st chromosome. Study of APP in mouse models can be challenging, however, so we took advantage of the simple nervous system, short life span and ease of molecular manipulation of the model nematode C. elegans. Specifically, we have generated transgenic worms that express a single additional wild-type copy of the worm APP ortholog (alp-1) or the human APP gene with a pan-neuronal promoter. We have found that, as in human AD, overexpression of apl-1 or human APP results in age-related degeneration of a specific subset of cholinergic neurons in C. elegans. Deficits in two natural behaviors, swimming and egg-laying, correlate with the accumulation of APP protein in these neurons and their eventual death. In addition, through genetic and pharmacological analyses, we have found that a specific serotonergic signaling pathway is both necessary and sufficient for degeneration of these neurons. Our results are consistent with studies in mice that have found that blockade of 5-HT6 signaling prevents age-related decline in memory, and hint at a role for 5-HT6 in APP-induced neurodegeneration. Moreover, if generalized to mammalian systems, our results offer a warning that the beneficial effects of certain Alzheimer's medications may be undermined by degeneration induced by non-specific elevation of serotonin through SSRIs.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jalz.2011.09.029
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Pierce‐Shimomura, J., & Crisp, A. (2011). P4‐284: Serotonergic blockade prevents age‐related neurodegeneration in C. elegans model of Alzheimer's disease. <em>Alzheimer s & Dementia</em>. https://doi.org/10.1016/j.jalz.2011.09.029
Vancouver
Pierce‐Shimomura J, Crisp A. P4‐284: Serotonergic blockade prevents age‐related neurodegeneration in C. elegans model of Alzheimer's disease. Alzheimer s & Dementia. 2011. doi:10.1016/j.jalz.2011.09.029.
BibTeX
@article{jon2011PSerot,
title = {P4‐284: Serotonergic blockade prevents age‐related neurodegeneration in C. elegans model of Alzheimer's disease},
author = {Jon Pierce‐Shimomura and Ashley Crisp},
journal = {Alzheimer s & Dementia},
year = {2011},
doi = {10.1016/j.jalz.2011.09.029},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Progress in Neurobiology 2025
Open access · CC-BY
Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological phenotypes of tauopathy mouse model of human Alzheimer's disease
HAL 2018
Preprint · OA
Le rôle de l’AMPK dans le vieillissement et la perte de plasticité neuronale liée au vieillissement chez C. elegans
Oxidative Medicine and Cellular Longevity 2016
Open access · CC-BY
Mitochondrial Health in Aging and Age‐Related Metabolic Disease
Cell stem cell 2022
Preprint · OA
Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease
Journal of Neuroscience 2015
Open access · OA
Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance
BMC Genomics 2006
Open access · CC-BY